Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wan-Ci Li"'
Autor:
Jin-Tao Huang, Shuai Zhang, Yi-Han Yang, Zi-Chen Zhang, Nan Jiang, Wan-Ci Li, Jian Shen, Bin-Yan Zhong, Xiao-Li Zhu
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 16 (2022)
Hepatocellular carcinoma (HCC) is one of the most common and deadly malignancies worldwide. Approximately, 80% of patients are initially diagnosed at intermediate or advanced stages, which means that curative therapies are unable to be performed. In
Externí odkaz:
https://doaj.org/article/80d15b09d3e641e4a4cbba9fb17e25f3
Autor:
Fei Yang, Gui-Li Xu, Jin-Tao Huang, Yu Yin, Wei Xiang, Bin-Yan Zhong, Wan-Ci Li, Jian Shen, Shuai Zhang, Jun Yang, Hong Peng Sun, Wan-Sheng Wang, Xiao-Li Zhu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundLocoregional therapy combined with systemic therapy can further improve the prognoses for HCC. However, the efficacy of TACE combined with ICIs and TKIs for HCC and whether this triple therapy can activate systemic immune response are still
Externí odkaz:
https://doaj.org/article/ee877308303c4344a4c9b590da36987e
Autor:
Fei Yang, Jun Yang, Wei Xiang, Bin-Yan Zhong, Wan-Ci Li, Jian Shen, Shuai Zhang, Yu Yin, Hong-Peng Sun, Wan-Sheng Wang, Xiao-Li Zhu
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
PurposeTo explore the safety and efficacy of transarterial chemoembolization (TACE) in combination with immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) for the treatment of unresectable hepatocellular carcinoma (uHCC).Materi
Externí odkaz:
https://doaj.org/article/95e1e03cf9d540dd8903e7e0216126e1
Autor:
Jin-Tao Huang, Bin-Yan Zhong, Nan Jiang, Wan-Ci Li, Shuai Zhang, Yu Yin, Jun Yang, Jian Shen, Wan-Sheng Wang, Xiao-Li Zhu
Publikováno v:
Journal of Hepatocellular Carcinoma.
Jin-Tao Huang,* Bin-Yan Zhong,* Nan Jiang,* Wan-Ci Li, Shuai Zhang, Yu Yin, Jun Yang, Jian Shen, Wan-Sheng Wang, Xiao-Li Zhu Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou, Peopleâ
Publikováno v:
Journal of vascular and interventional radiology : JVIR.
To investigate the safety and effectiveness of emergent transjugular intrahepatic portosystemic shunt (TIPS) as first-line therapy in patients with advanced cirrhosis with acute variceal hemorrhage.From July 2016 to June 2019, 76 patients with advanc